Matches in SemOpenAlex for { <https://semopenalex.org/work/W1998863388> ?p ?o ?g. }
- W1998863388 endingPage "2095" @default.
- W1998863388 startingPage "2087" @default.
- W1998863388 abstract "Cutaneous melanoma is a tumor with rising incidence and a very poor prognosis at the disseminated stage. Melanomas are characterized by frequent mutations in BRAF and also by overexpression of fibroblast growth factor 2 (FGF2), offering opportunities for therapeutic intervention. We investigated inhibition of FGF signaling and its combination with dacarbazine or BRAF inhibitors as an antitumor strategy in melanoma. The majority of melanoma cell lines displayed overexpression of FGF2 but also FGF5 and FGF18 together with different isoforms of FGF receptors (FGFRs) 1-4. Blockade of FGF signals with dominant-negative receptor constructs (dnFGFR1, 3, or 4) or small-molecule inhibitors (SU5402 and PD166866) reduced melanoma cell proliferation, colony formation, as well as anchorage-independent growth, and increased apoptosis. DnFGFR constructs also significantly inhibited tumor growth in vivo. Combination of FGF inhibitors with dacarbazine showed additive or antagonistic effects, whereas synergistic drug interaction was observed when combining FGFR inhibition with the multikinase/BRAF inhibitor sorafenib or the V600E mutant-specific BRAF inhibitor RG7204. In conclusion, FGFR inhibition has antitumor effects against melanoma cells in vitro and in vivo. Combination with BRAF inhibition offers a potential for synergistic antimelanoma effects and represents a promising therapeutic strategy against advanced melanoma." @default.
- W1998863388 created "2016-06-24" @default.
- W1998863388 creator A5012933847 @default.
- W1998863388 creator A5016628729 @default.
- W1998863388 creator A5026319974 @default.
- W1998863388 creator A5032169679 @default.
- W1998863388 creator A5033125669 @default.
- W1998863388 creator A5033593586 @default.
- W1998863388 creator A5035532329 @default.
- W1998863388 creator A5043913136 @default.
- W1998863388 creator A5059704501 @default.
- W1998863388 creator A5067062583 @default.
- W1998863388 creator A5067949509 @default.
- W1998863388 creator A5073606372 @default.
- W1998863388 creator A5076913706 @default.
- W1998863388 creator A5084496022 @default.
- W1998863388 creator A5088758787 @default.
- W1998863388 date "2011-10-01" @default.
- W1998863388 modified "2023-10-14" @default.
- W1998863388 title "Fibroblast Growth Factor Receptors as Therapeutic Targets in Human Melanoma: Synergism with BRAF Inhibition" @default.
- W1998863388 cites W1598196431 @default.
- W1998863388 cites W1686153396 @default.
- W1998863388 cites W1965540910 @default.
- W1998863388 cites W1966231228 @default.
- W1998863388 cites W1970344706 @default.
- W1998863388 cites W1971837077 @default.
- W1998863388 cites W1971947883 @default.
- W1998863388 cites W1982887112 @default.
- W1998863388 cites W1985737377 @default.
- W1998863388 cites W1988476050 @default.
- W1998863388 cites W2014061811 @default.
- W1998863388 cites W2015673035 @default.
- W1998863388 cites W2017407252 @default.
- W1998863388 cites W2023781626 @default.
- W1998863388 cites W2027230955 @default.
- W1998863388 cites W2027239974 @default.
- W1998863388 cites W2027364423 @default.
- W1998863388 cites W2031166424 @default.
- W1998863388 cites W2033208185 @default.
- W1998863388 cites W2034048944 @default.
- W1998863388 cites W2055172928 @default.
- W1998863388 cites W2063874384 @default.
- W1998863388 cites W2073363047 @default.
- W1998863388 cites W2076415360 @default.
- W1998863388 cites W2077945404 @default.
- W1998863388 cites W2078542230 @default.
- W1998863388 cites W2087913451 @default.
- W1998863388 cites W2124862241 @default.
- W1998863388 cites W2125037724 @default.
- W1998863388 cites W2137705897 @default.
- W1998863388 cites W2138178479 @default.
- W1998863388 cites W2139684524 @default.
- W1998863388 cites W2140765540 @default.
- W1998863388 cites W2150852167 @default.
- W1998863388 cites W2154196978 @default.
- W1998863388 cites W2157262448 @default.
- W1998863388 cites W2157467930 @default.
- W1998863388 cites W2163188200 @default.
- W1998863388 cites W2163992300 @default.
- W1998863388 cites W2333824332 @default.
- W1998863388 cites W2334880322 @default.
- W1998863388 doi "https://doi.org/10.1038/jid.2011.177" @default.
- W1998863388 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3383623" @default.
- W1998863388 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21753785" @default.
- W1998863388 hasPublicationYear "2011" @default.
- W1998863388 type Work @default.
- W1998863388 sameAs 1998863388 @default.
- W1998863388 citedByCount "66" @default.
- W1998863388 countsByYear W19988633882012 @default.
- W1998863388 countsByYear W19988633882013 @default.
- W1998863388 countsByYear W19988633882014 @default.
- W1998863388 countsByYear W19988633882015 @default.
- W1998863388 countsByYear W19988633882016 @default.
- W1998863388 countsByYear W19988633882017 @default.
- W1998863388 countsByYear W19988633882018 @default.
- W1998863388 countsByYear W19988633882019 @default.
- W1998863388 countsByYear W19988633882020 @default.
- W1998863388 countsByYear W19988633882021 @default.
- W1998863388 countsByYear W19988633882022 @default.
- W1998863388 countsByYear W19988633882023 @default.
- W1998863388 crossrefType "journal-article" @default.
- W1998863388 hasAuthorship W1998863388A5012933847 @default.
- W1998863388 hasAuthorship W1998863388A5016628729 @default.
- W1998863388 hasAuthorship W1998863388A5026319974 @default.
- W1998863388 hasAuthorship W1998863388A5032169679 @default.
- W1998863388 hasAuthorship W1998863388A5033125669 @default.
- W1998863388 hasAuthorship W1998863388A5033593586 @default.
- W1998863388 hasAuthorship W1998863388A5035532329 @default.
- W1998863388 hasAuthorship W1998863388A5043913136 @default.
- W1998863388 hasAuthorship W1998863388A5059704501 @default.
- W1998863388 hasAuthorship W1998863388A5067062583 @default.
- W1998863388 hasAuthorship W1998863388A5067949509 @default.
- W1998863388 hasAuthorship W1998863388A5073606372 @default.
- W1998863388 hasAuthorship W1998863388A5076913706 @default.
- W1998863388 hasAuthorship W1998863388A5084496022 @default.
- W1998863388 hasAuthorship W1998863388A5088758787 @default.
- W1998863388 hasBestOaLocation W19988633881 @default.
- W1998863388 hasConcept C126322002 @default.